N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis

Critical Care Medicine

Volumn 26, Issue 9, 1998, Pages 1490-1499

  Strand, Øystein A ^a,c   Leone, Anna M ^b   Giercksky, Karl Erik ^d   Skovlund, Eva ^e   Kirkebøen, Knut A ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Oxonon Analytical   (United States)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d National Cancer Hospital   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Coronary blood flow; Critical illness; Hypertension; Myocardium; N(G) monomethyl L arginine; Nitrates; Nitric oxide; Renal function; Septic shock; Survival

Indexed keywords

N(G) METHYLARGININE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; HEART INDEX; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; SWINE; URINE VOLUME;

EID: 0031708640     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199809000-00015     Document Type: Article

References (58)

1. Vincent J-L, Gris P, Coffernils M, et al: Myocardial depression characterizes the fatal course of septic shock. Surgery 1992; 111:660-667
2. Metrangolo L, Fiorillo M, Friedman G, et al: Early hemodynamic course of septic shock. Crit Care Med 1995; 23:1971-1975
3. G-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132-1138
4. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vitro. Eur J Pharmacol 1990; 182:591-595
5. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20(Suppl):S132-S134
6. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
7. Wright CE, Rees DD, Moncada S: The protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
8. Volk T, Ioannidis I, Hensel M, et al: Endothelial damage induced by nitric oxide: Synergism with reactive oxygen species. Biochem Biophys Res Commun 1995; 213:196-204
9. Draijer R, Atsma DE, van der Laarse A, et al: cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Circ Res 1995; 76:199-208
10. Gonzales C, Fernandez A, Martin C, et al: Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: Implications for endotoxin shock. Biochem Biophys Res Commun 1992; 186:150-156
11. MacArthur H, Mattammal MB, Westfall TC: A new perspective on the inhibitory role of nitric oxide in sympathetic nerve transmission. Biochem Biophys Res Commun 1995; 216:686-692
12. Brady AJB, Poole-Wilson PA, Harding SE, et al: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265:H176-H182
13. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
14. Schulz R, Panas DL, Catena R, et al: The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-α. Br J Pharmacol 1995; 114:27-34
15. Bateson AN, Jakiwczyk OM, Shulz R: Correlation between induction of myocardial iNOS mRNA, enzyme activity and plasma NO products during endotoxemia. Abstr. J Mol Cell Cardiol 1995; 27:A102
16. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
17. Lorente JA, Landin L, De Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21:1287-1295
18. G-monomethyl-L-arginine in cancer patients with shock. Abstr. Endothelium 1995; 3(Suppl):S57
19. Avontuur JAM, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995;76:418-425
20. Walsh CJ, Sugerman HJ, Mullen PG, et al: Monoclonal antibody to tumor necrosis factor a attenuates cardiopulmonary dysfunction in porcine Gram-negative sepsis. Ann Surg 1992; 127:138-145
21. BMDP Statistical Software Manual. Dixon WJ (Ed). Los Angeles, UCLA Press, 1990
22. Brandtzæg P, Kierulf P, Gaustad P, et al: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159:195-204
23. Casey L, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
24. Lowry SF: Sepsis and its complications: Clinical definitions and therapeutic prospects. Crit Care Med 1994; 22(July):S1-S2
25. Sigmon DH, Florentino-Pineda I, Van Dyke RA, et al: Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide. Anesthesiology 1995; 82:135-145
26. Galley HF, Neson LR, Webster NR: Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leukocytes. Br J Anaesth 1995; 75:326-329
27. Wang Y-X, Gavras I, Wierzba T, et al: Inhibition of nitric oxide, bradykinin and prostaglandins in normal rats. Hypertension 1991; 19(Suppl 2):II 225-II 261
28. Szabò C, Southan GJ, Thiemermann C, et al: Beneficial effects and improved survival in a rodent model of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1995,91:12472-12476
29. G-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med 1995; 23:1018-1024
30. G-methylarginine. Biochem Biophys Res Commun 1990; 170:96-103
31. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarine receptor antagonists. Circ Res 1993; 72:387-395
32. Teale DM, Atkinson AM: Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30:839-842
33. Robertson FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129:149-156
34. Evans T, Carpenter A, Silva A, et al: Inhibition of nitric oxide synthase in experimental Gram-negative sepsis. J Infect Dis 1994; 169:343-349
35. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/ nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990; 48:565-569
36. Shultz P, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90:1718-1725
37. Hutcheson IR, Whittle BJ, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101:815-820
38. Meadow W, Rudinsky B, Bell A, et al: Effects of inhibition of endothelium-derived relaxation factor on hemodynamics and oxygen utilization during group B streptococcal sepsis in piglets. Crit Care Med 1995; 23:705-714
39. Klemm P, Thiemermann C, Winklmaier G, et al: Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol 1995; 114:363-368
40. Minnard EA, Shou J, Naama H, et al: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129:142-148
41. G-monomethyl-L-arginine HCL (L-NMMA 546C88) improves survival in a conscious instrumented mouse model of endotoxin shock. Abstr. Endothelium 1995; 3:S116
42. G-monomethyl-L-arginine reversibly decreases cerebral flow in piglets. Crit Care Med 1994; 22:384-392
43. Urbanics R, Kapinya K, Dezsi L, et al: Dose dependent effects of the 7-nitro indazole, a neural NOS inhibitor on focal cerebral ischemia. Abstr. Endothelium 1995; 3:S58
44. Kirkebøen KA, Naess PA, Offstad J, et al: Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am J Physiol 1994; 266:H1516-H1527
45. Cohen RI, Huberfeld S, Genovese J, et al: A comparison between the acute effects of nitric oxide synthase inhibition and fluid resuscitation on myocardial function and metabolism in endotoxemic dogs. J Crit Care 1996; 11:27-36
46. Decking UKM, Flesche CW, Gødecke A: Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 1995; 268:H2460-H2465
47. Baydoun AR, Foale RD, Mann GE: Bacterial endotoxin rapidly stimulates prolonged endothelium dependent vasodilatation in the rat isolated heart. Br J Pharmacol 1993; 109:987-991
48. Smith REA, Palmer RMJ, Moncada S: Coronary vasodilation induced by endotoxin in the rabbit isolated perfused heart is nitric-oxide dependent and inhibited by dexamethasone. Br J Pharmacol 1991; 104:213-216
49. Preiser J-C, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23:259-264
50. Daemen-Gubbels CRGH, Groeneveld PHP, Groeneveld ABJ, et al: Methylene blue increases myocardial function in septic shock. Crit Care Med 1995; 23:363-1370
51. Yoshida M, Akaike T, Wada Y, et al: Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 1994; 202:923-930
52. Fenoy FJ, Ferrer P, Carbonell L, et al: Role of nitric oxide on papillary blood flow and pressure diuresis. Hypertension 1995; 25:408-415
53. Wennmalm Å, Benthin G, Petersson S: Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992; 106:507-508
54. Wennmalm Å, Benthin G, Eflund A, et al: Nitric oxide synthesis and metabolism in man. Ann NY Acad Sci 1994; 714:158-164
55. 15N-labeled nitrate in humans: Effects of diet supplementation with ascorbic acid. Cancer Res 1983; 43:1921-1925
56. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:1835-1840
57. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
58. Strand ØA, Granli T, Dahl R, et al: Serum nitrate levels in patients with severe sepsis and renal failure. Clinical Intensive Care 1997; 8:52-57